Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05782660 · ClinicalTrials.gov registry record · NA
Cash Benefits and Reproductive/Perinatal Health
A NA study of Pregnancy Related and Maternal Care Patterns, sponsored by Harvard Medical School (HMS and HSDM).
- Active
- Registry status
- NA
- Development phase
- 3,615
- Enrollment target
- 1
- Study location
NCT05782660: Active NA study of Pregnancy Related and Maternal Care Patterns, sponsored by Harvard Medical School (HMS and HSDM).
NCT05782660 is a NA study of Pregnancy Related and Maternal Care Patterns that is active but no longer recruiting, run by Harvard Medical School (HMS and HSDM). The registered enrollment target is 3,615 participants, above the 1,926-participant average among 99 other Pregnancy Related trials with a reported enrollment target (88% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05782660, a NA study of Pregnancy Related and Maternal Care Patterns, is active but no longer recruiting, sponsored by Harvard Medical School (HMS and HSDM).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,615 participants
- Enrollment target
- 1
- Study location
Study Summary
During the first two years of the COVID-19 pandemic, the City of Chelsea, Massachusetts held a lottery to allocate cash benefits to its residents for ten months. Using data from the Chelsea Eats program, the investigators propose to study the impact of the cash benefit on reproductive and perinatal health.
Conditions Studied
Interventions
- OTHER Cash Benefit
- OTHER No Cash Benefit
Study Locations (1)
Massachusetts
- Harvard Medical School - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,615 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What the registry record for NCT05782660 still lists
NCT05782660 is an interventional study that assigns participants to a tested intervention. Its 3,615 participants enrollment target places it among the larger protocols in the corpus, above the 1,926-participant average among 99 other Pregnancy Related trials with a reported enrollment target (88% higher).
The record links to 3 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which Cash Benefit is the first listed.
NCT05782660 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05782660 about?
NCT05782660 is a clinical study titled "Cash Benefits and Reproductive/Perinatal Health". During the first two years of the COVID-19 pandemic, the City of Chelsea, Massachusetts held a lottery to allocate cash benefits to its residents for ten months. Using data from the Chelsea Eats program, the investigators propose to study the impact of the cash benefit on reproductive and perinatal ...
What is the current status of trial NCT05782660?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,615 participants. The study started on 2020-07-27. Estimated completion is 2025-08-31.
What conditions does trial NCT05782660 study?
This clinical trial studies the following conditions: Pregnancy Related, Maternal Care Patterns, Miscarriage.
What interventions are being tested in trial NCT05782660?
The interventions under investigation include: Cash Benefit (OTHER), No Cash Benefit (OTHER).
Who is sponsoring clinical trial NCT05782660?
This trial is sponsored by Harvard Medical School (HMS and HSDM), which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05782660 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05782660's enrollment target sits among peer trials
3,615 6th of 99 higher than 94 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Accountability for Care Through Undoing Racism & Equity for Moms
RECRUITING · NA
-
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
MAMA Tot - Healthy Weight Parallel Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06354920 · 3,624 participants · NA
M-Well Bonding Bundle to Improve Patient-Physician Relationships
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06501118 · 3,600 participants · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
- NCT06919419 · 3,600 participants · NA
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI